Neuroblastoma surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
(3 intermediate revisions by the same user not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Surgery|Surgical intervention]] is [[Cure|curative]] as a single therapeutic modality for management of low risk neuroblastoma [[Patient|patients]]. In intermediate risk patients, [[Surgery|surgical intervention]] must be followed by [[chemotherapy]]. However, the benefits of [[surgery]] to achieve complete [[tumor]] [[resection]] in high risk [[Patient|patients]] with [[metastatic disease]] is not clearly demonstrated. | |||
==Surgery== | ==Surgery== | ||
* Surgical intervention alone may be curative as a single therapeutic modality for the management of '''low risk''' neuroblastoma patients. | * [[Surgery|Surgical intervention]] alone may be [[Cure|curative]] as a single therapeutic modality for the management of '''low risk''' neuroblastoma [[Patient|patients]].<ref>{{Cite journal | ||
* Surgical intervention must be followed by chemotherapy for the management of '''intermediate risk''' neuroblastoma patients.<ref>{{Cite journal | | author = [[Andrew M. Davidoff]] | ||
| title = Neuroblastoma | |||
| journal = [[Seminars in pediatric surgery]] | |||
| volume = 21 | |||
| issue = 1 | |||
| pages = 2–14 | |||
| year = 2012 | |||
| month = February | |||
| doi = 10.1053/j.sempedsurg.2011.10.009 | |||
| pmid = 22248965 | |||
}}</ref> | |||
* [[Surgery|Surgical intervention]] must be followed by [[chemotherapy]] for the management of '''intermediate risk''' neuroblastoma [[Patient|patients]].<ref>{{Cite journal | |||
| author = [[Suk-Bae Moon]], [[Kwi-Won Park]], [[Sung-Eun Jung]] & [[Woong-Jae Youn]] | | author = [[Suk-Bae Moon]], [[Kwi-Won Park]], [[Sung-Eun Jung]] & [[Woong-Jae Youn]] | ||
| title = Neuroblastoma: treatment outcome after incomplete resection of primary tumors | | title = Neuroblastoma: treatment outcome after incomplete resection of primary tumors | ||
Line 20: | Line 31: | ||
| pmid = 19629500 | | pmid = 19629500 | ||
}}</ref> | }}</ref> | ||
* The potential benefit of aggressive surgical approaches to achieve complete tumor resection in '''high-risk''' patients with metastatic disease has not been clearly demonstrated.<ref name="gov">Neuroblastoma treatment–for health professionals. National Cancer Institute (2015) http://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq#section/_1 Accessed on October, 8 2015</ref><ref>{{Cite journal | * The potential benefit of aggressive [[Surgery|surgical approaches]] to achieve complete [[tumor]] [[resection]] in '''high-risk''' [[Patient|patients]] with [[metastatic disease]] has not been clearly demonstrated.<ref name="gov">Neuroblastoma treatment–for health professionals. National Cancer Institute (2015) http://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq#section/_1 Accessed on October, 8 2015</ref><ref>{{Cite journal | ||
| author = [[Valeria Smith]] & [[Jennifer Foster]] | | author = [[Valeria Smith]] & [[Jennifer Foster]] | ||
| title = High-Risk Neuroblastoma Treatment Review | | title = High-Risk Neuroblastoma Treatment Review | ||
Line 51: | Line 62: | ||
| doi = 10.1200/JCO.2012.45.9339 | | doi = 10.1200/JCO.2012.45.9339 | ||
| pmid = 23284039 | | pmid = 23284039 | ||
}}</ref><ref>{{Cite journal | |||
| author = [[Victoria Castel]], [[J. A. Tovar]], [[E. Costa]], [[J. Cuadros]], [[A. Ruiz]], [[V. Rollan]], [[J. I. Ruiz-Jimenez]], [[R. Perez-Hernandez]] & [[A. Canete]] | |||
| title = The role of surgery in stage IV neuroblastoma | |||
| journal = [[Journal of pediatric surgery]] | |||
| volume = 37 | |||
| issue = 11 | |||
| pages = 1574–1578 | |||
| year = 2002 | |||
| month = November | |||
| pmid = 12407542 | |||
}}</ref> | }}</ref> | ||
* Surgical complications following neuroblastoma resection may include:<ref>Neuroblastomas. Patient (2015) http://patient.info/doctor/neuroblastomas Accessed on October, 11 2015</ref> | * Surgical [[Complication (medicine)|complications]] following neuroblastoma [[resection]] may include:<ref>Neuroblastomas. Patient (2015) http://patient.info/doctor/neuroblastomas Accessed on October, 11 2015</ref> | ||
:* Intussusception | :* [[Intussusception]] | ||
:* Internal haemorrhage due to vessel injuries | :* [[Internal bleeding|Internal haemorrhage]] due to [[Blood vessel|vessel]] injuries | ||
:* Nerve injuries | :* [[Nerve]] injuries | ||
==References== | ==References== |
Latest revision as of 14:28, 5 March 2019
Neuroblastoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neuroblastoma surgery On the Web |
American Roentgen Ray Society Images of Neuroblastoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]Haytham Allaham, M.D. [3]
Overview
Surgical intervention is curative as a single therapeutic modality for management of low risk neuroblastoma patients. In intermediate risk patients, surgical intervention must be followed by chemotherapy. However, the benefits of surgery to achieve complete tumor resection in high risk patients with metastatic disease is not clearly demonstrated.
Surgery
- Surgical intervention alone may be curative as a single therapeutic modality for the management of low risk neuroblastoma patients.[1]
- Surgical intervention must be followed by chemotherapy for the management of intermediate risk neuroblastoma patients.[2]
- The potential benefit of aggressive surgical approaches to achieve complete tumor resection in high-risk patients with metastatic disease has not been clearly demonstrated.[3][4][5][6][7]
- Surgical complications following neuroblastoma resection may include:[8]
- Intussusception
- Internal haemorrhage due to vessel injuries
- Nerve injuries
References
- ↑ Andrew M. Davidoff (2012). "Neuroblastoma". Seminars in pediatric surgery. 21 (1): 2–14. doi:10.1053/j.sempedsurg.2011.10.009. PMID 22248965. Unknown parameter
|month=
ignored (help) - ↑ Suk-Bae Moon, Kwi-Won Park, Sung-Eun Jung & Woong-Jae Youn (2009). "Neuroblastoma: treatment outcome after incomplete resection of primary tumors". Pediatric surgery international. 25 (9): 789–793. doi:10.1007/s00383-009-2417-8. PMID 19629500. Unknown parameter
|month=
ignored (help) - ↑ Neuroblastoma treatment–for health professionals. National Cancer Institute (2015) http://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq#section/_1 Accessed on October, 8 2015
- ↑ Valeria Smith & Jennifer Foster (2018). "High-Risk Neuroblastoma Treatment Review". Children (Basel, Switzerland). 5 (9). doi:10.3390/children5090114. PMID 30154341. Unknown parameter
|month=
ignored (help) - ↑ E. Stanton Adkins, Robert Sawin, Robert B. Gerbing, Wendy B. London, Katherine K. Matthay & Gerald M. Haase (2004). "Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study". Journal of pediatric surgery. 39 (6): 931–936. PMID 15185228. Unknown parameter
|month=
ignored (help) - ↑ Thorsten Simon, Beate Haberle, Barbara Hero, Dietrich von Schweinitz & Frank Berthold (2013). "Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis". Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31 (6): 752–758. doi:10.1200/JCO.2012.45.9339. PMID 23284039. Unknown parameter
|month=
ignored (help) - ↑ Victoria Castel, J. A. Tovar, E. Costa, J. Cuadros, A. Ruiz, V. Rollan, J. I. Ruiz-Jimenez, R. Perez-Hernandez & A. Canete (2002). "The role of surgery in stage IV neuroblastoma". Journal of pediatric surgery. 37 (11): 1574–1578. PMID 12407542. Unknown parameter
|month=
ignored (help) - ↑ Neuroblastomas. Patient (2015) http://patient.info/doctor/neuroblastomas Accessed on October, 11 2015